Why pharmaceutical companies need to move beyond therapies and embrace total care solutions
As is the case with many emerging technologies, we’re now in the early stages of defining consensus and understanding around what digital therapeutics (DTx) are and how they work.
For Pharmas to realize the full potential digital therapeutics, they need to take a much more comprehensive view of conditions and problems that HCPs and people suffering from disease and chronicconditions face.
Download the Report to learn more about:
Moving from discrete therapies to holistic care solutions
Identifying and understanding the latest in digital therapies and products
How to utilize human-centered design to find new opportunities in this developing market
frog is a leading global creative consultancy, part of Capgemini Invent. We challenge the status quo to craft and build transformative human experiences that win hearts and move markets. Partnering with passionate leaders and visionary entrepreneurs, we apply creativity, strategy, design and data to re-invent businesses, drive growth and orchestrate customer centric transformation. Together we strive to shape a regenerative future that is both sustainable and inclusive for businesses, people and planet.